Trial Profile
A study of CHO-H01 for the treatment of cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2017
Price :
$35
*
At a glance
- Drugs CHO H01 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 20 Jul 2017 New trial record
- 19 Jul 2017 Accordign to a CHO Pharma media release, the company anticipates to initiate this study in Jul 2017.